United States blood pressure medication consumers are being warned.
On Friday, November 9th, 2018, a massively popular blood pressure medication was recalled for containing N-nitrosodiethylamine (NDEA), a severely dangerous carcinogen.
The blood pressure medication being recalled is a losartan blood pressure (hydrochlorothiazide 100 milligram/25 milligram tablets with the lot number JB8912) tables from Sandoz. The carcinogen discovered could lead to cancer, according to the International Agency for Research on Cancer.
The discovery of the chemical impurities in the blood pressure medication surface just months after international regulators discovered impurities from a major Chinese drugmaker. Since the original discovery, several drugs shipped to the United States are being found in the US supply.
According to FiercePharma, the “FDA pointed out that Sandoz’s losartan drug products make up less than 1% of the total losartan drug products in the U.S. market.”
Since the discovery of N-nitrosodiethylamine (NDEA), the FDA has been testing “Sartan” products. Sartan products refer to the “the class of drugs called angiotensin receptor blockers (ARBs), as the class name suggests, are drugs that block the action of angiotensin. Specifically, ARBs prevent angiotensin II from binding to the angiotensin II receptor on blood vessels and other tissues.”
Please pray that the affected supply is stopped before distribution to consumers and pray that those who have consumed the drug are safe from the cancer-causing carcinogen.
Share this story on Facebook!